At the luncheon meeting at the Parmelia in Perth this afternoon, the Executive Director, Nathan Buzza, who has an excellent record with other companies, alluded to probable further expansion both within and outside Australia and in the not too distant future, the massive market in the USA.
This company is really going to outperform most others.
The space within which they are placed, medical technology, will assure a very bright future.
NRR Price at posting:
6.5¢ Sentiment: Buy Disclosure: Held
